6 September 2007 in Journal of Molecular Histology
28 February 2011 in Hepatology
The healthy adult human liver expresses low levels of major histocompatibility complex class II (MHC II) and undetectable levels of immune costimulatory molecules. However, high levels of MHC II, CD40, and B7 family molecules are expressed in the activated Kupffer cells and hepatocytes of patients with viral hepatitis. The precise role of these molecules in viral clearance and immune-mediated liver injury is not well understood. We hypothesized that parenchymal CD40 expression enhances T cell recruitment and effector functions, which may facilitate viral clearance and alleviate liver injury. To test this hypothesis, we generated novel liver-specific, conditional CD40 transgenic mice, and we challenged them intravenously with a recombinant replication-deficient adenovirus carrying Cre recombinase (AdCre). Wild-type mice infected with AdCre developed a relatively mild course of viral hepatitis and recovered spontaneously. CD40 expression in the livers of transgenic animals, however, resulted in CD80 and CD86 expression. The dysregulation of population dynamics and effector functions of intrahepatic lymphocytes (IHLs) resulted in severe lymphocytic infiltration, apoptosis, necroinflammation, and serum alanine aminotransferase elevations in a dose-dependent fashion. To our surprise, an early expansion and subsequent contraction of IHLs (especially CD8+ and natural killer cells), accompanied by increased granzyme B and interferon-γ production, did not lead to faster viral clearance in CD40 transgenic mice.
Conclusion:
Our results demonstrate that hepatic CD40 expression does not accelerate adenoviral clearance but rather exacerbates liver injury. This study unveils a previously unknown deleterious effect of hepatic CD40 on adenovirus-induced liver inflammation. (Hepatology 2011;)
25 March 2009 in Journal of Obstetrics and Gynaecology Research
1 January 2016 in Journal of Otolaryngology - Head & Neck Surgery
Background: The presence of a plane between the lingual tonsils and the underlying soft tissue has not been confirmed. The objective of this study is to ascertain the presence and the characteristics about this plane for surgical use. Methods: Five cadaver heads were obtained for dissection of the lingual tonsils. Six permanent sections of previous tongue base biopsies were reviewed. Robot assisted lingual tonsillectomy was performed using the dissection technique from the cadaver dissection. Results: In each of the 5 cadavers, an avascular plane was revealed deep to the lingual tonsils. Microscopic review of the tongue base biopsies revealed a clear demarcation between the lingual tonsils and the underlying minor salivary glands and muscle tissue. This area was relatively avascular. Using the technique described above, a lingual tonsillectomy using TORS was performed with similar findings from the cadaver dissections. Conclusions: A surgical plane for lingual tonsillectomy exists and may prove to have a role with lingual tonsillectomy with TORS.
16 November 2020 in Journal of Biomedical Optics
Oral squamous cell carcinoma (OSCC) accounts for almost 94% of all oral cancers with new diagnoses every year solely in the United States (US).1 The five-year survival rate of patients with advanced OSCC involving regional lymph node invasion or beyond is (regional) and 20% (distant) but can be as high as 84% when cancers are diagnosed and treated when detected in the localized primary site.2 It is estimated that the percent of cases diagnosed at advanced stages, defined as regional or distant cancers, range from 64 to beyond 70%, motivating approaches that facilitate early detection and intervention.3,4 The most comprehensive US source is the SEER Cancer Statistics Review (CSR) 1975–2016, which indicates 31% of cases are diagnosed at early stage (local), 64% at advanced stages (regional or distant), and 5% at unknown stages.5 OSCCs, primarily oral epithelial dysplasia (OED), have potential to develop from neoplasia, an abnormal growth of the epithelium due to a malignant or a benign precancerous lesion.6,7 With grade of OEDs remaining the key factor to assess risk for transformation of such lesions, there have been increased efforts to detect OEDs harbored in lesions to aid in clinical decisions.8,9 There remains a need for methods that more effectively support detection efforts.
1 August 2005 in Archives of Pathology & Laboratory Medicine